Bharat Bio successfully completes Phase III trials of new oral...

Dununu.com Dununu

إعلان مُمول

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

RSS Feed National

نشر بتاريخ

76

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.

Read Full Article

جارٍ التحميل...

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!

Mechi Customs Office collects nearly Rs 13 billion in revenue over 10 months

JHAPA: The Mechi Customs Office has collected Rs 12.94 billion in revenue during the first 10...

بواسطة 0 11

New Orleans Archdiocese agrees to pay nearly $180M to victims of clergy sexual abuse

The Archdiocese of New Orleans has agreed to a $179.2 million settlement for clergy sexual abuse...

بواسطة 0 13

Europe Must Change Its Approach to Africa

In recent years, China has surpassed Europe in terms of both trade with Sub-Saharan Africa and...

بواسطة 0 14

India Test Squad For England Tour Live: Who will lead India in the series?

بواسطة 0 26

Four parliamentary committees holding meetings today

KATHMANDU: Four parliamentary committees under the Federal Parliament are scheduled to convene...

بواسطة 0 26